CentreStone Ventures is a life sciences focused private venture capital fund investing primarily in companies developing early stage therapeutics, medical devices, diagnostics and new drug delivery methods.
Companies that interest CentreStone develop products for large markets with unmet clinical needs. They have technologies based on solid intellectual property, a combination of entrepreneurial and technical expertise, and the potential to become leaders in their markets.
Based in Winnipeg, Manitoba, CentreStone is strategically located at the geographic centre of North America. This central location provides CentreStone ready access to investment opportunities from leading research centres across the continent, with a specific focus on opportunities in Western Canada and the U.S. Midwest. In addition to providing capital, CentreStone actively partners with scientific entrepreneurs providing the structure, support and guidance required to establish a strong foundation for commercial development.